These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27542674)

  • 1. MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.
    Lai YY; Shen F; Cai WS; Chen JW; Feng JH; Cao J; Xiao HQ; Zhu GH; Xu B
    Tumour Biol; 2016 Oct; 37(10):14165-14171. PubMed ID: 27542674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma.
    Liu J; Su Z; Zeng Y; Zhang H; Yang S; Liu G
    Oncol Rep; 2017 Mar; 37(3):1445-1450. PubMed ID: 28184924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
    Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M; Li M; Wang T; Linghu E; Wu B
    Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
    Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
    Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
    Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
    Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
    Zhang M; Li M; Li N; Zhang Z; Liu N; Han X; Liu Q; Liao C
    Oncol Rep; 2017 Mar; 37(3):1772-1778. PubMed ID: 28184926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.
    Hung TM; Ho CM; Liu YC; Lee JL; Liao YR; Wu YM; Ho MC; Chen CH; Lai HS; Lee PH
    PLoS One; 2014; 9(2):e89446. PubMed ID: 24586785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells.
    Dang YW; Zeng J; He RQ; Rong MH; Luo DZ; Chen G
    Asian Pac J Cancer Prev; 2014; 15(12):4969-76. PubMed ID: 24998573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
    Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
    FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma.
    Xie Y; Wei RR; Huang GL; Zhang MY; Yuan YF; Wang HY
    Med Oncol; 2014 Mar; 31(3):844. PubMed ID: 24464213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
    Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
    Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.